Thymosin beta-15 predicts for distant failure in patients with clinically localized prostate cancer—results from a pilot study
- 1 May 2000
- Vol. 55 (5) , 635-638
- https://doi.org/10.1016/s0090-4295(00)00462-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinNew England Journal of Medicine, 1997
- p53, bcl-2 and Retinoblastoma Proteins as Long-Term Prognostic Markers in Localized Carcinoma of the ProstateJournal of Urology, 1997
- Neoadjuvant androgen suppression with radiation in the management of locally advanced adenocarcinoma of the prostate: Experimental and clinical resultsUrology, 1997
- Thymosin β15: A novel regulator of tumor cell motility upregulated in metastatic prostate cancerNature Medicine, 1996
- Identification of intermediate-risk prostate cancer patients treated with radical radiotherapy suitable for neoadjuvant hormone studiesRadiotherapy and Oncology, 1996
- Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the radiation therapy oncology groupUrology, 1995
- Patterns of care and rtog studies in prostate cancer: Long-term survival, hazard rate observations, and possibilities of cureInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Prognostic factors in prostate cancer: Analysis of 874 patients treated with radiation therapyCancer, 1993
- Technical and tumor-related factors affecting outcome of definitive irradiation for localized carcinoma of the prostateInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Radiation therapy for localized diseaseCancer, 1993